NOD2 and lung carcinoma: In addition, patients with NOD2 polymorphisms are reportedly at high risk of lymphoma, colorectal cancer, gastric cancer, breast cancer, ovarian cancer, lung cancer, and laryngeal cancer, but at low risk of kidney cancer [32].